Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation.

"Declarations Ethical approval and consent to participateAll procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Medical Review Ethics Committee Region Arnhem-Nijmegen and was registered on clinicaltrials.gov (NCT03828838). All subjects provided written informed consent before study entry. Consent for publicationPatients signed informed consent regarding publishing their data. Competing interestsThe authors have no conflicts of interest to declare that are relevant to the content of this article. Competing interests The authors have no conflicts of interest to declare that are relevant to the content of this article."

"Funding Partial financial support was received from the Radboud Oncology Foundation and the Dutch Prostate Cancer Foundation."

"Clinical trial registration This study was approved by the Medical Review Ethics Committee Region Arnhem-Nijmegen on January 23, 2018 and was registered on clinicaltrials.gov (NCT03828838)."